he prime shareholder of FTSE 250 chemical compounds maker Elementis has referred to as for the enterprise to be bought in a scathing letter calling out the agency’s administration for “value destructive capital allocation” and “inability to improve operating performance”.
Franklin Mutual Series, an autonomous specialist funding supervisor inside Franklin Templeton, holds 9.8% of shares in Elementis, which makes key substances in antiperspirants and paint, having first invested in 2020.
